N@N

Kendall Law Group Investigates CPEX Pharmaceuticals, Inc. Acquisition for Shareholders

^{Published on 2011-01-04 08:55:19 - Market Wire}
 

DALLAS--([ BUSINESS WIRE ])--[ Kendall Law Group ], led by former federal judge Joe Kendall, is investigating CPEX Pharmaceuticals, Inc. (NASDAQ: CPEX) for shareholders in connection with the proposed acquisition by a subsidiary of Footstar, Inc. The national securities firma™s investigation seeks to determine whether CPEX and its Board breached their fiduciary duties by entering into the agreement without properly shopping for a deal that would provide better value for shareholders. If you are a CPEX shareholder and would like additional information about your rights, contact the Kendall Law Group at 877-744-3728 or by email at [ skendall@kendalllawgroup.com ].

On January 4, 2011, the companies announced the definitive merger agreement under which CPEX would be acquired by a subsidiary of Footstar, in a transaction valued at approximately $76.6 million. Under the terms of the agreement, CPEX stockholders will receive $27.25 in cash for each share of CPEX common stock. The firma™s investigation seeks to determine whether the transaction provides proper value for CPEX shareholders.

Kendall Law Group was founded by a former federal judge, includes a former United States Attorney, prosecutors and securities lawyers who are experienced in complex securities litigation. The firm has been counsel in numerous merger and acquisition cases nationwide, including some of the largest transactions in the United States.